‘Collateral’ lethality may offer new therapeutic approach for cancers of the pancreas, stomach and colon

Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known as ‘collateral lethality,’ which may create new options for development of therapies for several cancers.